Notice: This company recently went public with an IPO on the week of December 23rd 2024. They issued 15,000,000 shares at $10.00 per share. We will continue to update data for TDACU as it becomes available. NASDAQ:TDACU Translational Development Acquisition (TDACU) Stock Price, News & Analysis $10.03 +0.02 (+0.20%) (As of 05:27 PM ET) Add Share Share Stock Analysis Stock AnalysisChartCompetitorsTrends About Translational Development Acquisition Stock (NASDAQ:TDACU) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get TDACU alerts:Sign Up Key Stats Today's Range$10.02▼$10.0350-Day Range N/A52-Week Range$10.01▼$10.03Volume2,138 shsAverage Volume95,779 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewTrident Acquisitions Corp. does not have significant operations. It intends to enter into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more target businesses primarily in the oil and gas or other natural resource sector. Trident Acquisitions Corp. was incorporated in 2016 and is headquartered in New York, New York.Read More… Receive TDACU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Translational Development Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address TDACU Stock News HeadlinesTranslational Development Acquisition Corp. Announces Closing of $172. ...December 24, 2024 | gurufocus.comSee More Headlines TDACU Stock Analysis - Frequently Asked Questions How have TDACU shares performed this year? Translational Development Acquisition's stock was trading at $10.01 at the beginning of the year. Since then, TDACU shares have increased by 0.2% and is now trading at $10.03. View the best growth stocks for 2024 here. When did Translational Development Acquisition IPO? Translational Development Acquisition (TDACU) raised $150 million in an initial public offering (IPO) on the week of December 23rd 2024. The company issued 15,000,000 shares at a price of $10.00 per share. When does Translational Development Acquisition's quiet period expire? Translational Development Acquisition's quiet period expires on Monday, February 3rd. Translational Development Acquisition had issued 15,000,000 shares in its public offering on December 23rd. The total size of the offering was $150,000,000 based on an initial share price of $10.00. During Translational Development Acquisition's quiet period, insiders and any underwriters involved in the IPO are prevented from issuing any research reports or earnings estimates for the company because of regulations issued by the Securities and Exchange Commission. Following the expiration of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company. How do I buy shares of Translational Development Acquisition? Shares of TDACU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorFinance, Insurance, And Real Estate Industry Investment Offices Sub-IndustryTrading Current SymbolNASDAQ:TDACU CUSIPN/A CIKN/A WebN/A Phone(413) 204-2769FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$5.64 million Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableN/A BetaN/A 10 Best Stocks to Own in 2025Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio. Get This Free Report This page (NASDAQ:TDACU) was last updated on 12/30/2024 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | Sponsored3 CENT Crypto to Explode December 16th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored>>>RE: Buy this Stock before Trump Takes Office!To make sure everyone has the opportunity to get in, closes for good at midnight on January 1st, we're lowerin...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Translational Development Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Translational Development Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
